James Emmett Young - Chief Financial Officer at TriSalus Life Sciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
TLSI, TLSIW on Nasdaq
All Insider Reports
All Insider Reports

James Emmett Young - trading volume in the past year for TriSalus Life Sciences, Inc.

Holdings reported by James Emmett Young for TriSalus Life Sciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 36.5K $206K $5.65 Feb 18, 2025 Direct
Common Stock 30K $170K $5.65 Feb 18, 2025 By Kathleen A. Young Living Trust
Employee Stock Option (right to buy) 75K Jan 27, 2025 Direct Common Stock

Transactions reported by James Emmett Young for TriSalus Life Sciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.